ArticleCancer science2022

Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.

Takuya Sakashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.